Your browser doesn't support javascript.
loading
Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses.
de Costa, Fernanda; Yendo, Anna Carolina A; Cibulski, Samuel P; Fleck, Juliane D; Roehe, Paulo M; Spilki, Fernando R; Gosmann, Grace; Fett-Neto, Arthur G.
Afiliação
  • de Costa F; Plant Physiology Laboratory, Center for Biotechnology and Department of Botany, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil; Faculty of Pharmacy, UFRGS, Porto Alegre, Brazil.
  • Yendo AC; Plant Physiology Laboratory, Center for Biotechnology and Department of Botany, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil; Faculty of Pharmacy, UFRGS, Porto Alegre, Brazil.
  • Cibulski SP; Fepagro Animal Health - Institute of Veterinary Research "Desidério Finamor" (IPVDF), Eldorado do Sul, Brazil, and Virology Laboratory, Microbiology Department, UFRGS, Porto Alegre, Brazil.
  • Fleck JD; Molecular Microbiology Laboratory, Feevale University, Novo Hamburgo, Brazil.
  • Roehe PM; Fepagro Animal Health - Institute of Veterinary Research "Desidério Finamor" (IPVDF), Eldorado do Sul, Brazil, and Virology Laboratory, Microbiology Department, UFRGS, Porto Alegre, Brazil.
  • Spilki FR; Molecular Microbiology Laboratory, Feevale University, Novo Hamburgo, Brazil.
  • Gosmann G; Faculty of Pharmacy, UFRGS, Porto Alegre, Brazil.
  • Fett-Neto AG; Plant Physiology Laboratory, Center for Biotechnology and Department of Botany, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
PLoS One ; 9(8): e105374, 2014.
Article em En | MEDLINE | ID: mdl-25148077
Inactivated polio vaccines (IPV) have an important role at the final stages of poliomyelitis eradication programs, reducing the risks associated with the use of attenuated polio vaccine (OPV). An affordable option to enhance vaccine immunogenicity and reduce costs of IPV may be the use of an effective and renewable adjuvant. In the present study, the adjuvant activity of aqueous extract (AE) and saponin fraction QB-90 from Quillaja brasiliensis using poliovirus antigen as model were analyzed and compared to a preparation adjuvanted with Quil-A, a well-known saponin-based commercial adjuvant. Experimental vaccines were prepared with viral antigen plus saline (control), Quil-A (50 µg), AE (400 µg) or QB-90 (50 µg). Sera from inoculated mice were collected at days 0, 28, 42 and 56 post-inoculation of the first dose of vaccine. Serum levels of specific IgG, IgG1 and IgG2a were significantly enhanced by AE, QB-90 and Quil-A compared to control group on day 56. The magnitude of enhancement was statistically equivalent for QB-90 and Quil-A. The cellular response was evaluated through DTH and analysis of IFN-γ and IL-2 mRNA levels using in vitro reestimulated splenocytes. Results indicated that AE and QB-90 were capable of stimulating the generation of Th1 cells against the administered antigen to the same extent as Quil-A. Mucosal immune response was enhanced by the vaccine adjuvanted with QB-90 as demonstrated by increases of specific IgA titers in bile, feces and vaginal washings, yielding comparable or higher titers than Quil-A. The results obtained indicate that saponins from Q. brasiliensis are potent adjuvants of specific cellular and humoral immune responses and represent a viable option to Quil-A.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poliomielite / Saponinas / Vacina Antipólio de Vírus Inativado / Adjuvantes Imunológicos / Quillaja Limite: Animals País/Região como assunto: America do sul / Brasil Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poliomielite / Saponinas / Vacina Antipólio de Vírus Inativado / Adjuvantes Imunológicos / Quillaja Limite: Animals País/Região como assunto: America do sul / Brasil Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos